Dupilumab in adolescents with moderate to severe atopic dermatitis: a 32-week real-world experience during the COVID-19 pandemic

被引：26
|
作者：
Hansel, K. [1 ]
Patruno, C. [2 ]
Antonelli, E. [1 ]
Dal Bello, G. [3 ]
Napolitano, M. [4 ]
Fabbrocini, G. [5 ]
Grieco, T. [6 ]
Pellacani, G. [6 ]
Fargnoli, M. C. [7 ]
Esposito, M. [7 ]
Piras, V. [8 ]
Zucca, M. [8 ]
Girolomoni, G. [3 ]
Stingeni, L. [1 ]
机构：
[1] Univ Perugia, Dermatol Sect, Dept Med & Surg, Perugia, Italy
[2] Magna Graecia Univ Catanzaro, Sect Dermatol, Hlth Sci Dept, Catanzaro, Italy
[3] Univ Verona, Sect Dermatol & Venereol, Dept Med, Verona, Italy
[4] Univ Molise, Dept Med & Hlth Sci Vincenzo Tiberio, Campobasso, Italy
[5] Univ Naples Federico II, Sect Dermatol, Dept Clin Med & Surg, Naples, Italy
[6] Sapienza Univ Rome, Dermatol Unit, Rome, Italy
[7] Univ LAquila, Dept Biotechnol & Appl Clin Sci, Dermatol, Laquila, Italy
[8] Univ Cagliari, Dept Med Sci & Publ Hlth, Dermatol Clin, Cagliari, Italy
来源：
CLINICAL AND EXPERIMENTAL DERMATOLOGY | 2022年 / 47卷 / 01期
关键词：
D O I：
10.1111/ced.14862
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：165 / 167
页数：3
相关论文
共 50 条
  • [31] A real-world Australian experience of upadacitinib for the treatment of severe atopic dermatitis
    Tran, Vanessa
    Ross, Gayle
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2023, 64 (04) : e352 - e356
  • [32] A real-world study to assess the disease control of moderate to severe atopic dermatitis in patients receiving dupilumab therapy, with atopic dermatitis control tool in Gulf countries
    Alfalasi, Amani
    Ameen, Ahmed
    Al Lafi, Atlal
    El Gendi, Ayman
    Saad, Waqas
    Ismail, Ahmed
    Al Naeem, Ayman
    Goturu, Srikumar
    Al-Ahmed, Nasser
    Dayem, Hussein Abdel
    Nanda, Arti
    Tawdy, Amira
    Alogayell, Lulwa
    Iraqi, Mohamed
    Abdul Hay, Nasser
    El Enezi, Manar
    Walkhinde, Subash
    Kamal, Marwa
    Aldhuhoori, Muna
    Almesfer, Asem
    Abd Elwhab, Amira
    Al Hawsawi, Khalid Ali
    Barakat, Ahmad
    Chmayse, Sahar
    Hafiz, Mohammed
    Chouikrat, Zahir
    Fahmy, Monica
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2025, 36 (01)
  • [33] A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis
    Fargnoli, M. C.
    Esposito, M.
    Ferrucci, S.
    Girolomoni, G.
    Offidani, A.
    Patrizi, A.
    Peris, K.
    Costanzo, A.
    Malara, G.
    Pellacani, G.
    Romanelli, M.
    Amerio, P.
    Cristaudo, A.
    Flori, M. L.
    Motolese, A.
    Betto, P.
    Patruno, C.
    Pigatto, P.
    Peccianti, C.
    Stinco, G.
    Zalaudek, I.
    Bianchi, L.
    Boccaletti, V.
    Cannavo, S. P.
    Cusano, F.
    Lembo, S.
    Mozzillo, R.
    Gallo, R.
    Potenza, C.
    Rongioletti, F.
    Tiberio, R.
    Grieco, T.
    Micali, G.
    Persechino, S.
    Pettinato, M.
    Pucci, S.
    Stingeni, L.
    Caruso, C.
    Argenziano, G.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (02) : 1146 - 1149
  • [34] Real-world effectiveness and safety of dupilumab for the treatment of moderate to severe atopic dermatitis in Indian patients: A multi centric retrospective study
    Dhar, Sandipan
    De, Abhishek
    Srinivas, Sahana M.
    INDIAN JOURNAL OF DERMATOLOGY, 2021, 66 (03) : 297 - 301
  • [35] Real-world Experience With Upadacitinib in Adolescents and Adults With Refractory Atopic Dermatitis: A 24-week Retrospective Study
    Naharro-Rodriguez, J.
    Berna-Rico, E.
    Perez-Bootelloy, F. J.
    Perez-Garcia, B.
    ACTAS DERMO-SIFILIOGRAFICAS, 2024, 115 (06): : T615 - T617
  • [36] Efficacy of Dupilumab for Severe Atopic Dermatitis Co-occurring With Asthma in a Real-World Setting
    Pose, K.
    Laorden, D.
    Hernandez, N.
    Villamanan, E.
    Quirce, S.
    Dominguez-Ortega, J.
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2023, 33 (03) : 217 - 219
  • [37] Real-World Effectiveness and Safety of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis: A 16-Week Study in Japan
    Hagino, Teppei
    Uchiyama, Akihiko
    Onda, Marina
    Kosaka, Keiji
    Araki, Takeshi
    Motegi, Sei-ichiro
    Saeki, Hidehisa
    Fujimoto, Eita
    Kanda, Naoko
    DERMATITIS, 2025,
  • [38] Impact of the COVID-19 pandemic on adults with moderate-to-severe atopic dermatitis in the Dutch general population
    Zhang, Junfen
    Loman, Laura
    Kamphuis, Esme
    Schuttelaar, Marie L. A.
    JAAD INTERNATIONAL, 2022, 6 : 86 - 93
  • [39] COVID-19 Does Not Influence the Time to Relapse Following Dupilumab Discontinuation in Patients With Moderate-to-Severe Atopic Dermatitis
    Sun, Xiu-Kun
    DERMATITIS, 2024, 35 (05) : 523 - 524
  • [40] Effectiveness and safety of dupilumab in adults with moderate and severe atopic dermatitis in Colombia: Real-life experience
    Londono, Julian
    Perez, Lucia
    Moreno, Sergio
    Chapman, Edgardo
    Garcia, Maria Beatriz
    Celis, Ana Maria
    Munoz, Maria Angelica
    Castillo, David
    Sanchez, Jorge
    Arevalo, Yaicith
    Lozano, Ana
    Alvis-Zakzuk, Nelson J.
    Munoz, Cesar
    Botero, Laura
    Beltran, Catalina
    Garcia, Elizabeth
    WORLD ALLERGY ORGANIZATION JOURNAL, 2023, 16 (04):
12345